---
title: "12 Health Care Stocks Moving In Friday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294558593.md"
description: "In Friday's after-market session, several healthcare stocks saw significant movement. Gainers included Universe Pharmaceuticals (UPC), which surged 91.1% to $6.04, and BGM Group (BGM), up 11.63%. Other gainers were NRX Pharmaceuticals, Bicara Therapeutics, Medicus Pharma, and Akanda. Conversely, Losers featured NewGenIvf Group (NIVF) dropping 18.1%, Profusa (PFSA) falling 17.93%, Valion Bio (VBIO) down 12.91%, Autonomix Medical (AMIX) declining 9.89%, AEON Biopharma (AEON) falling 9.56%, and Rocket One (RKTO) decreasing 8.75%."
datetime: "2026-07-31T21:06:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294558593.md)
  - [en](https://longbridge.com/en/news/294558593.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294558593.md)
---

# 12 Health Care Stocks Moving In Friday's After-Market Session

### Gainers

-   **Universe Pharmaceuticals** (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's after-market session. The company's market cap stands at $2.2 million.
-   **BGM Group** (NASDAQ:BGM) stock rose 11.63% to $0.31. The market value of their outstanding shares is at $108.8 million.
-   **NRX Pharmaceuticals** (NASDAQ:NRXP) stock increased by 6.89% to $3.37. The company's market cap stands at $133.5 million.
-   **Bicara Therapeutics** (NASDAQ:BCAX) shares moved upwards by 6.27% to $28.8. The company's market cap stands at $1.7 billion.
-   **Medicus Pharma** (NASDAQ:MDCX) shares moved upwards by 6.06% to $0.29. The company's market cap stands at $14.8 million.
-   **Akanda** (NASDAQ:AKAN) shares increased by 5.83% to $5.62. The company's market cap stands at $3.4 million.

### Losers

-   **NewGenIvf Group** (NASDAQ:NIVF) stock decreased by 18.1% to $0.67 during Friday's after-market session. The market value of their outstanding shares is at $2.9 million.
-   **Profusa** (NASDAQ:PFSA) stock declined by 17.93% to $0.87.
-   **Valion Bio** (NASDAQ:VBIO) stock fell 12.91% to $0.27. The company's market cap stands at $1.1 million.
-   **Autonomix Medical** (NASDAQ:AMIX) shares declined by 9.89% to $3.1. The market value of their outstanding shares is at $1.9 million.
-   **AEON Biopharma** (AMEX:AEON) stock fell 9.56% to $0.27. The company's market cap stands at $11.2 million.
-   **Rocket One** (NASDAQ:RKTO) stock decreased by 8.75% to $0.73. The company's market cap stands at $17.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)
- [PFSA.US](https://longbridge.com/en/quote/PFSA.US.md)
- [BCAX.US](https://longbridge.com/en/quote/BCAX.US.md)
- [NRXP.US](https://longbridge.com/en/quote/NRXP.US.md)
- [RKTO.US](https://longbridge.com/en/quote/RKTO.US.md)
- [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md)
- [BGM.US](https://longbridge.com/en/quote/BGM.US.md)
- [NIVF.US](https://longbridge.com/en/quote/NIVF.US.md)
- [VBIO.US](https://longbridge.com/en/quote/VBIO.US.md)
- [MDCX.US](https://longbridge.com/en/quote/MDCX.US.md)
- [AEON.US](https://longbridge.com/en/quote/AEON.US.md)
- [UPC.US](https://longbridge.com/en/quote/UPC.US.md)
- [NRXPW.US](https://longbridge.com/en/quote/NRXPW.US.md)
- [MDCXW.US](https://longbridge.com/en/quote/MDCXW.US.md)
- [NIVFW.US](https://longbridge.com/en/quote/NIVFW.US.md)
- [NVACW.US](https://longbridge.com/en/quote/NVACW.US.md)

## Related News & Research

- [Akanda unit First Towers & Fiber completes 200-km Mexico fiber network installation](https://longbridge.com/en/news/295839594.md)
- [Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update | MDCX Stock News](https://longbridge.com/en/news/295715209.md)
- [AEON Biopharma Q2 net loss narrows on warrant gain; cash runway extended](https://longbridge.com/en/news/295705604.md)
- [Rocket One Launches Swarm Stage AI Drone-Swarm Threat Emulation Platform for U.S. Military Counter-UAS](https://longbridge.com/en/news/296226492.md)
- [NRX Pharmaceuticals reports $18.0M net loss for first half 2026, $26.7M cash on hand](https://longbridge.com/en/news/296102653.md)